Lophius Biosciences Granted Key Patent in the US
The USTPO has granted the US patent US 78293318 entitled “Use of urea-adjuvanted polypeptides for diagnosis, prophylaxis, and therapy” to Lophius Biosciences.
Read MoreThe USTPO has granted the US patent US 78293318 entitled “Use of urea-adjuvanted polypeptides for diagnosis, prophylaxis, and therapy” to Lophius Biosciences.
Read MoreRice University scientists have found a way to predict rapidly whether a new strain of the influenza virus should be included in the annual seasonal flu vaccine.
Read MoreRecently in New York City, Siebert outlined some key points surrounding the importance of rapid HIV testing and his company’s efforts at developing new testing technology.
Read MoreRoche Diagnostics and CapitalBio will enter a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide.
Read MoreIn an effort to increase patient participation and the diagnosis of early colon cancers, Kaiser Permanente switched their annual screening test from the traditional guaiac kit to the FIT method in 2006.
Read More